• Giuseppe Fiorentino, Anna Annunziata, Rosa Cauteruccio, Raffaele Cobuccio, and Mario Caputi.
• Chest. 2014 Mar 1;145(3 Suppl):448A.

Session TitlePediatric PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: to evaluate the feasibility of low-level BCPAP in pediatric patients affected by cronic respiratory failure secondary to congenital heart disease (univentricular heart) with tracheostomy tube.Methods8 pediatric patients, aged between 3 and 20 months with congenital heart disease corrected surgically. After tracheostomy, it was not possible to wean according to classical procedures of weaning. Our approach was: progressive increase of the diameter of the cannula and reduction of pressure support and acts in SIMV. Spontaneous breathing cycles were performed with Boussignac CPAP.ResultsThe patients had a median stay of 48 days in the intensive care unit during which they had an endotracheal tube for 25 days and a TT for 23 days (18.5 days in patients without infections). The patients received BCPAP for a median of 14 days.ConclusionsThe lightweight BCPAP system was well tolerated without tube obstructions or accidental decannulations. This device also has the advantage of maintaining PEEP also in case of concomitant use of FBS and tracheal aspirations, without interrupting the CPAP treatment.Clinical ImplicationsThe use of CPAP Boussignac can reduce the time of weaning in pediatric patients with congenital heart disease and tracheostomy tube.DisclosureThe following authors have nothing to disclose: Giuseppe Fiorentino, Anna Annunziata, Rosa Cauteruccio, Raffaele Cobuccio, Mario CaputiNo Product/Research Disclosure Information.

23 keywords...

hide…